Publications by authors named "Brock M Miniard"

Claim this Profile
A
A new generation of serotype chimeric infectivity-enhanced conditionally replicative adenovirals: the safety profile of ad5/3-Δ24 in advance of a phase I clinical trial in ovarian cancer patients.
Kenneth H Kim, Michael J Ryan, James E Estep, Brock M Miniard, Thomas L Rudge

Hum Gene Ther· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis